Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype
Michael D Walsh, Mark Clendenning, Elizabeth Williamson, Sally-Ann Pearson, Rhiannon J Walters, Belinda Nagler, David Packenas, Aung K Win, John L Hopper, Mark A Jenkins, Andrew M Haydon, Christophe Rosty, Dallas R English, Graham G Giles, Michael A McGuckin, Joanne P Young, Daniel D Buchanan
MODERN PATHOLOGY | NATURE PUBLISHING GROUP | Published : 2013
Related Projects (1)
Awarded by NHMRC
We thank Charmaine Smith, Lisa Oates, and Sonia Terre'Blanche from the Cancer Council Victoria for their tireless assistance with tissue block acquisition, Diane McKeone and Erika Pavluk for technical and database assistance, the late Professor Jeremy jass for performing some of the histopathology reviews, and Dr Karine Rousseau (University of Manchester, UK) for her gift of the MUC5B monoclonal antibody used in the study. The authors are also indebted to Heather Matthews for providing graphics support. We would like to thank the various clinical laboratories that very kindly made access to tissue blocks possible. This study was supported by a grant from the NHMRC. Christophe Rosty is the Jass Pathology Fellow, John L Hopper is an NMHRC Australia Fellow, and Mark A Jenkins and Michael A McGu ckin are supported by NHMRC Senior Research Fellowships. MCCS recruitment was funded by Vic Health, and ongoing support has been provided from recurrent funding by Cancer Council Victoria. This work was funded in part by a NHMRC Program Grant (APP209057).